Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | November 08, 2012 | November 09, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date November 08, 2012 · Filed November 09, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share CreditsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 85,113.1272 |
Reported balance
After 2012-11-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2012-11-08 · Grant · Acquired 2,099.9354 · Balance 85,113.1272 F1: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. |
| Common StockSEC Table I · non-derivative | Direct | 11,353.3218 |
Reported balance
Holding disclosure · report date 2012-11-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 11,353.3218 |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan.
F2: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2004 Filed Aug 6, 2004 18:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 49 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001198220-04-000002 · c0001198220d20040806f4f.xml · derivative · entry 2 HEARD MARIAN L · CIK 0001198220 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,270 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F1 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| July 07, 2004 Filed Jul 9, 2004 19:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 24 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001198222-04-000015 · c0001198220d20040709f4f.xml · derivative · entry 2 HEARD MARIAN L · CIK 0001198220 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,221 Underlying: Common Stock · 24 shares Expires not disclosed F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1996 Directors Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| May 12, 2004 Filed May 14, 2004 18:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,704 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001174477-04-000004 · c0001198220d20040514f4f.xml · derivative · entry 2 HEARD MARIAN L · CIK 0001198220 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,167 Underlying: Common Stock · 2,704 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1996 Directors Stock Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| November 05, 2003 Filed Nov 7, 2003 14:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 284 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001174477-03-000035 · c0001198220d20031107f4f.xml · derivative · entry 2 HEARD MARIAN L · CIK 0001198220 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,401 Underlying: Common Stock · 284 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1996 Directors Stock Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.